1.82
+0.1(+6.06%)
Currency In USD
| Previous Close | 1.72 |
| Open | 1.77 |
| Day High | 1.82 |
| Day Low | 1.73 |
| 52-Week High | 2.67 |
| 52-Week Low | 0.93 |
| Volume | 2,471 |
| Average Volume | 65,066 |
| Market Cap | 53.85M |
| PE | -7.91 |
| EPS | -0.23 |
| Moving Average 50 Days | 1.39 |
| Moving Average 200 Days | 1.48 |
| Change | 0.1 |
If you invested $1000 in Dyadic International, Inc. (DYAI) 10 years ago, it would be worth $1,978.26 as of December 26, 2024 at a share price of $1.82. Whereas If you bought $1000 worth of Dyadic International, Inc. (DYAI) shares 5 years ago, it would be worth $342.75 as of December 26, 2024 at a share price of $1.82.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology
GlobeNewswire Inc.
Nov 21, 2024 1:30 PM GMT
Grant Received from the Bill & Melinda Gates Foundation to Fund Development of Affordable TherapeuticsJUPITER, Fla., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (NASDAQ: DYAI), a global biotechnology company, announced today that i
Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
GlobeNewswire Inc.
Nov 04, 2024 9:30 PM GMT
JUPITER, Fla., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and an
Dyadic Expands Global Presence with Participation in Key Industry Events
GlobeNewswire Inc.
Oct 09, 2024 12:00 PM GMT
JUPITER, Fla., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic” or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the large-scale, efficient manufacturing of proteins for human and animal vaccines, therapeut